These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20648735)

  • 21. Lipid management with statins. The lower the better?
    Laufs U; Liao JK; Böhm M
    Z Kardiol; 2004 Jan; 93(1):4-9. PubMed ID: 14740235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statins, cholesterol, and the prevention of coronary heart disease.
    Freeman MW
    FASEB J; 2006 Feb; 20(2):200-1. PubMed ID: 16449790
    [No Abstract]   [Full Text] [Related]  

  • 23. High-dose statin therapy: benefits and safety in aggressive lipid lowering.
    Toth PP; Davidson MH
    J Fam Pract; 2008 May; 57(5 Suppl High-Dose):S29-36. PubMed ID: 18662521
    [No Abstract]   [Full Text] [Related]  

  • 24. Cholesterol 2001. Rationale for lipid-lowering in older patients with or without CAD.
    Aronow WS
    Geriatrics; 2001 Sep; 56(9):22-5, 28-30. PubMed ID: 11582971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intensive cholesterol lowering: no longer a myth.
    Bitzur R; Harats D
    Isr Med Assoc J; 2005 Dec; 7(12):816-7. PubMed ID: 16382708
    [No Abstract]   [Full Text] [Related]  

  • 26. LDL-Cholesterol is the King.
    Goumas GS
    Angiology; 2009; 60(3):387-8. PubMed ID: 19497926
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prevention and treatment of coronary heart disease: lowering LDL, increasing HDL or monitoring both?].
    Windler E
    Internist (Berl); 1996 Jun; 37(6):643-6. PubMed ID: 8768000
    [No Abstract]   [Full Text] [Related]  

  • 28. Hypercholesterolemia. The evidence supports use of statins.
    Aronow WS
    Geriatrics; 2003 Aug; 58(8):18-20, 26-8, 31-2. PubMed ID: 12938249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Coronary heart disease patient after myocardial infarct. Must LDL cholesterol now be reduced to 70 mg/dl?]].
    MMW Fortschr Med; 2005 Dec; 147(49-50):17-8. PubMed ID: 16401004
    [No Abstract]   [Full Text] [Related]  

  • 30. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES).
    Raggi P; Davidson M; Callister TQ; Welty FK; Bachmann GA; Hecht H; Rumberger JA
    Circulation; 2005 Jul; 112(4):563-71. PubMed ID: 16009795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS).
    Lim PO; Yee KM
    Circulation; 1999 Aug; 100(6):686. PubMed ID: 10441109
    [No Abstract]   [Full Text] [Related]  

  • 33. [When statins alone are not enough. Putting a vice grip on cholesterol].
    MMW Fortschr Med; 2002 Jun; 144(23):52-3. PubMed ID: 12119909
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of hypercholesterolemia with statins].
    Erikssen J; Madsen S
    Tidsskr Nor Laegeforen; 1997 Sep; 117(22):3216-20. PubMed ID: 9411860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Broader indication for treatment with statins; the 'heart protection study'].
    Cleophas TJ
    Ned Tijdschr Geneeskd; 2002 Dec; 146(50):2453; author reply 2453-4. PubMed ID: 12518529
    [No Abstract]   [Full Text] [Related]  

  • 36. [Mediterranean diet and statins against cardiovascular disease].
    Håkansson J
    Lakartidningen; 2012 Sep 5-11; 109(36):1540-3. PubMed ID: 23016236
    [No Abstract]   [Full Text] [Related]  

  • 37. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.
    Glueck CJ; Aregawi D; Agloria M; Khalil Q; Winiarska M; Munjal J; Gogineni S; Wang P
    Clin Ther; 2006 Jun; 28(6):933-42. PubMed ID: 16860175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of cholesterol-lowering treatment.
    Law M; Wald NJ
    Lancet; 2006 Feb; 367(9509):469-70; author reply 470-1. PubMed ID: 16473115
    [No Abstract]   [Full Text] [Related]  

  • 39. Are patients taking statins, which are HMG-CoA reductase inhibitors, to reduces their cholesterol, the danger of being deficient in coenzyme Q?
    Wood EJ
    IUBMB Life; 2004 Jul; 56(7):433-6. PubMed ID: 15545221
    [No Abstract]   [Full Text] [Related]  

  • 40. When a statin fails.
    Med Lett Drugs Ther; 2009 Jul; 51(1317):58-60. PubMed ID: 19636290
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.